Pharmaceutical Intermediates

Quality Control of Pharmaceutical Intermediates

Published 2025-05-30

Identity, assay, impurity profile and residual solvents are the four pillars.

Quality control of an intermediate covers identity confirmation, assay, impurity profile and residual solvent content. Each attribute is defined by a specification agreed with the customer and demonstrated with validated analytical methods. Consistent documentation is what allows an intermediate to be used in a regulated supply chain.

Related Compounds

C7H6O3
CAS 69-72-7C7H6O3MW 138.12
View Details

Related Knowledge Articles

Industrial Insights

Fluorinated Building Blocks in Drug Design

Fluorine substitution changes metabolic stability, acidity and binding.

CRO / CDMO

Choosing a CRO or CDMO Partner

Evaluation criteria for outsourcing synthesis and manufacturing.

Drug Development

Scale-Up From Gram to Kilogram

What changes when a laboratory route moves into a pilot plant.

Looking for a Specific Compound?

Send us your CAS Number, chemical structure or project requirements and our scientific team will evaluate your request.

Request a Quote